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Abstract The localisation of metallothionein isoform mRNAs 
in rat hepatoma (H4) cells was investigated using two approaches, 
namely Northern hybridisation of total RNA extracted from free, 
cytoskeletal-bound and membrane-bound polysomes isolated by 
a sequential detergent/salt extraction procedure and in situ hy- 
bridisation. The cytoskeletal-bound polysomes were enriched in 
metallothionein-I (MT-I) and c-myc mRNAs but showed a signif- 
icantly lower enrichment in MT-II mRNA. These findings indi- 
cate that the MT-I mRNA is localised to the cytoskeleton during 
translation. In situ hybridisation using a biotin-labelled oligonu- 
cleotide probe revealed a predominantly perinuclear localisation 
for the MT-I mRNA. 
for MT, such as protection against oxicity of heavy metal ions 
[12], an antioxidant role [13] and in the regulation of hepatic 
zinc and copper metabolism [14-16]; however, at present it is 
not known whether the isoforms of this protein are conferred 
with different functions in any cell type. Neither is it known if 
the isoforms possess different subcellular distribution, al- 
though, interestingly, under certain circumstances MT has been 
found in the nucleus [17,18]. This paper provides evidence that 
in rat hepatoma cells MT-I mRNA is translated in cytoskeletal- 
bound polysomes (CBP) and present predominantly in the 
perinuclear cytoplasm. 
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I. Introduction 
The localisation of certain mRNAs to distinct subcellular 
sites has been well documented in oocytes and early embryos 
of Xenopus and Drosophila, and there is increasing evidence 
that, similarly, mRNAs for some intracellular proteins are lo- 
calised in differentiated somatic mammalian cells (for reviews 
see [1,2]). For example, the mRNA coding for fl-actin is present 
in the peripheral cytoplasm in spreading fibroblasts [3], whilst 
in muscle vimentin mRNA is found close to the costameres [4]: 
in such cases it appears that the mRNAs are localised close to 
the site of function of the encoded protein, suggesting that 
localisation of some mRNAs may play a role in facilitating 
subsequent protein targeting. There have been a large number 
of reports which demonstrate an association of mRNA and 
polyribosomes (polysomes) with the cytoskeleton [5-8], and in 
addition recent evidence suggests that cytoskeletal elements are 
involved in the localisation process [9,10]. 
Metallothioneins (MTs) are a group of cysteine-rich, low 
molecular weight intracellular proteins which have a high affin- 
ity for divalent metals such as zinc (Zn2+), copper (Cu2+), cad- 
mium (Cd 2+) and mercury (Hg 2+) and monovalent metals such 
as copper (Cu +) and silver (Ag+). These metals, as well as other 
endogenous factors such as glucocorticoid and certain cyto- 
kines, are also capable of inducing MT gene expression [11]. In 
mammals, there are multiple MT genes giving rise to a family 
of isoforms with highly-conserved cysteine-rich regions. The 
number of isoforms varies between species, there being two 
major isoforms in the rat. Several functions have been proposed 
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2. Materials and methods 
2.1. Cell culture 
Rat liver hepatoma (H4-II-E-C3, ECACC number 85061112) cells 
were grown in 90-mm Petri dishes in Dulbeccos minimal Eagle's me- 
dium supplemented with 12% fetal calf serum at 37°C in an atmosphere 
of 5% CO2. MT was induced by addition of zinc chloride and the 
concentration of zinc in aliquots of medium removed prior to cell 
fractionation or fixation was determined by atomic absorption spectro- 
photometry. 
2.2. Cell fractionation 
Cells were pre-treated with emetine (100 ng/ml medium) for 30 min 
in order to maintain mRNA-ribosome interactions [19], rinsed 3 times 
with PBS (10 mM phosphate buffer, pH 7.4 containing 0.9% NaC1) and 
then scraped into buffer A (10 mM Tris containing 0.25 M sucrose, 
25 mM KC1, 5 mM MgC12, and 0.5 mM CaCI2). Cytosolic, cytoskeletal 
and membrane fractions were then isolated by a sequential detergent/ 
salt extraction procedure, ssentially as described previously [20]: treat- 
ment with 2.5 ml of buffer A containing 0.1% nonidet-P-40 (10 min, 
4°C) lysed the cells and released a fraction containing free polysomes 
(FP); extraction with 2.5 ml of buffer A containing 160 mM KC1 for 
10 min at 4°C released cytoskeletal-bound polysomes (CBP) and treat- 
ment with 2.5 ml of buffer A containing 130 mM KC1, 0.5% N-P40 and 
0.5% deoxycholate solubilized the endoplasmic reticulum and released 
membrane-bound polysomes (MBP). Aliquots of fractions were taken 
for enzyme and protein assays and the remainder layered on a 40% 
sucrose cushion and polysomes separated from monosomes and lighter 
material by centrifugation at32,000 x g for 17 h [21,22]. All buffers and 
cushion solutions were autoclaved as appropriate; xtraction buffers 
contained RNAse inhibitor RNAsin (133 units/ml; Promega, UK). 
Lactic dehydrogenase was measured spectrophotometrically [23]. 
Actin and vimentin were assayed by enzyme-linked immunosorbent 
assay [8,24] using actin and vimentin standards and anti-actin from 
Sigma Chemical Co., Poole, Dorset, UK and anti-vimentin from 
Amersham International Ltd, Amersham, UK. 
2.3. RNA extraction and hybridisation 
Total RNA was extracted from cells or polysome pellets by the 
acid/guanidinium/phenol/chloroform method of Chomczynski and 
Sacchi [25] and assessed by the A26JA280 absorbance ratio. RNA species 
were then separated by electrophoresis through a 2.2 M formaldehyde, 
1.2% agarose gel and then transferred to a positively charged nylon 
membrane (Genescreen, NEN Dupont Ltd.) by capillary blotting. 
RNA was fixed to the membrane by exposure to UV light and the 
0014-5793195/$9.50 © 1995 Federation of European Biochemical Societies. All rights reserved. 
SSD1 0014-5793(95)01000-9 
P Mahon et al./FEBS Letters 373 (1995) 76~80 77 
membranes were stored dry until required. The membranes were pre- 
hybridised for 6 h at 42°C with 10% dextran sulphate, 0.2% bovine 
serum albumin, 0.2% ficoll, 0.2% polyvinylpyrrolidone, 0.1 mg/ml 
salmon sperm DNA, 50% formamide, 0.1% sodium pyrophosphate, 1% 
SDS and 50 mM Tris-HC1, pH 7.5. 
The c-myc probe was a 1.8 kbp HindIII fragment derived from a 
cDNA corresponding to the three exons of the c-myc gene (a gift from 
Dr. M. Cole, Princeton University, NJ, USA). The MT-I and MT-II 
oligonucleotide probes were a 28-mer and 30-mer complementary to 
5'-untranslated region sequences and specific to the MT-I and MT-II 
isoforms (Vasconcelos, Beattie and Hesketh, unpublished observa- 
tions): they were synthesized by the cyanoethyl phosphoramide method 
in a Cruachem PS 250 automated DNA synthesizer. The glut-1 probe 
was a 2.0 kb Bgll fragment from the rat cDNA (a gift from Dr. R. 
Knott, Dept. of Opthalmology, University of Aberdeen). 100 ng of the 
c-myc and Glut-1 probes were labelled with [32P]dCTP by random 
priming (Amersham Multiprime kit) and the labelled probe was sepa- 
rated from free nucleotides by gel filtration through a Sephadex G-50 
column. The MT-I probe was end-labelled with [32p]ATP by incubation 
with 4 units T4-kinase (New England Biolabs Ltd.) and purified using 
Clontech chroma spin-10 columns. The labelled probes were then 
added to the pre-hybridisation mix and the membranes hybridized for 
20 h at 42°C. The membranes were then washed to remove non-specif- 
ically bound probe. In the case of c-myc and glut-1 hybridizations the 
membranes were first washed in 2 x SSC twice at room temperature for 
10 min, followed by 0.5% SSC, 1% SDS at 65°C for 1 h twice. In the 
case of MT-I hybridisations, the membranes were initially washed with 
6 x SSC at room temperature for 10 min twice, followed by 0.1% SSC, 
0.1% SDS at 48°C for 20 min. Specific hybridization was then detected 
either by autoradiography using Hyperfilm-MP (Amersham Interna- 
tional, UK) at -70°C or with a Packard instantimager which was used 
to quantify the hybridisation signal from the specifically-bound probe. 
Loading errors were corrected by a control hybridisation with a 1.4 kb 
probe for 18S rRNA [26]. 
2.4. In situ hybridisation 
Cells were grown on glass chamber slides and washed three times 
with PBS before fixation with 4% paraformaldehyde (PFA) in PBS. 
After partial dehydration i  70% ethanol for 1 h at 4°C cells were 
permeabilised by treatment with 0.2% Triton X-100 in 4% PFA/PBS 
(4°C). RNAse controls were then treated with 1000 ¢tg/ml RNase A in 
10 mM Tris-HC1, pH 7.5 containing 0.5 M NaC1 for 30 min at 37°C 
and a further fixation performed. After incubation in 50% formamide, 
2 x SSC at room temperature for 10 min the cells were hybridised 
overnight with 0.2 ng/gtl biotinylated MT-I probe (identical in sequence 
to the probe used for northern blot hybridizations) at 37°C; control 
patches were incubated with the in situ hybridization mix alone and 
contained no probe. After hybridization non-specifically bound probe 
was removed by washing in increasingly stringent SSC solutions and 
the bound probe was detected by incubation with alkaline phosphatase 
linked to streptavidin (Amersham International, UK) and then addi- 
tion of 4-nitro blue tetrazolium for 2 3 h. 
3. Results 
3.1. Induction of metallothionein 
MT-I mRNA levels are low in cells grown in normal  culture 
medium containing only 0.5 ~g zinc/ml (Fig. la). In order to 
study MT-I mRNA distribution it was necessary to increase 
MT expression and this was achieved by exposing the cells to 
zinc for up to 18 h prior to extraction. Northern hybridisation 
showed an increasing induction in MT-I mRNA expression as 
the zinc concentrat ion was increased up to 6 ¢tg/ml. After cor- 
rection of the hybridisation signal for that achieved with a 
probe for glyceraldehyde 3-phosphate dehydrogenase mRNA 
there was approximately a 5-fold increase in transcript levels 
in comparison to control cells (results not shown). All subse- 
quent experiments were carried out using cells in Zn-supple- 
mented medium (final concentrat ion 6 ¢tg/ml) for 18 h prior to 
assessment of MT-I mRNA distribution. 
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Fig. 1. Induction and distribution of MT-I mRNA studied by Northern 
hybridization. (A) Northern hybridization with the MT-I probe show- 
ing induction of MT-I mRNA by the presence of zinc for 12 h. Each 
lane was loaded with 20 gig of total RNA, and each Zn treatment was 
performed in duplicate. As can be seen from this autoradiograph there 
is an increase in MT-I mRNA levels with increasing amounts of zinc 
present in the medium with the largest induction clearly being produced 
with a zinc concentration f 6/~g/ml. (B) Northern hybridization show- 
ing the distribution of the MT-I message in the three polysome fractions 
from cells in which MT was induced by incubation with 6/zg/ml Zn for 
18 h. FP, free polysomes; CBP, cytoskeletal-bound polysomes; MBP, 
membrane-bound polysomes. Each lane was loaded with 20 ¢tg total 
RNA which was extracted from a polysome preparation of each frac- 
tion. As can be seen the hybridization signal is most intense for the CBP. 
3.2. Fractionation of H4 cells to yield three polysome 
populations: free, cytoskeletal- and membrane-bound 
Free, cytoskeletal and membrane-bound polysome fractions 
were isolated from H4 cells using a sequential detergent/salt 
extraction procedure [20]. A concentrat ion of 0.1% NP-40 in 
low salt extraction buffer was sufficient o release 87% of lactic 
dehydrogenase activity and on this basis the fraction produced 
by such treatment was judged to be a cytosolic fraction contain- 
ing free polysomes (FP). This concentrat ion of NP-40 is some- 
what higher than that required with 3T3 fibroblasts but less 
than that required for HepG2 and ascites cells: it emphasises 
that the concentrat ion eeded to release the bulk of the cy- 
tosolic material varies between different cell lines [7,8,20,22]. 
Enzyme- linked immunoassay of vimentin and actin in fractions 
from three replicate experiments howed an enrichment of 
these proteins in the high salt extract (Fig. 2) suggesting that, 
as in other cell lines, the salt treatment caused breakdown of 
the cytoskeleton. Thus, by virtue of the effect of the increased 
salt on release of cytoskeletal proteins this fraction was deemed 
to contain material (including polysomes and mRNA)  associ- 
ated with the cytoskeleton. 
Further characterisation was carried out by Northern hy- 
bridisation to study the distribution of two marker mRNAs  in 
the three polysome fractions. Firstly, c-myc, which has consis- 
tently been found to be present in the cytoskeletal-bound pol- 
ysome fraction in a number  of cell lines [20,22,27] was found 
to be enriched in the presumptive cytoskeletal fraction in H4 
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Fig. 2. Determination of the concentration of actin and vimentin present in the cytosolic, cytoskeletal nd membrane fractions by ELISA. Results 
are shown as means + S.E.M. from three fractionation experiments. ELISA was performed using 400 pg total protein from each fraction the amount 
of actin present calculated by comparison with absorbance produced by 3-100 pg actin and 1.5-50 pg vimentin standards; the results expressed in 
terms of picograms of actin (A) and vimentin (B) per 400 pg total protein. 
cells (Table 1). Secondly, the mRNA which codes for the inte- 
gral membrane protein glucose transporter 1 (glut-l), and 
which is therefore a marker for the membrane-bound pol- 
ysomes, was found to be highly enriched in the MBP fraction. 
To determine if the total RNA fractions obtained from the 
polysome pellet contain the same proportion of poly(A +) 
mRNA in relation to total RNA,  a slot blot was prepared in 
which 2 pg of total RNA from each fraction was loaded in 
duplicate onto a nylon membrane. After hybridisation with a 
25-mer polyT-oligonucleotide nd-labelled with [32p]ATE 
quantification of the specifically-bound DNA indicated that 
comparable amounts of the oligonucleotide were bound by FR 
CBP and MBP (759, 961 and 1005 counts bound respectively). 
This indicates that a given amount of total RNA from each 
polysome fraction contained approximately the same amount 
of mRNA.  
MT-I mRNA was found to be enriched in the CBP fraction 
(Fig. lb). Quantification of the data, and correction for hy- 
bridisation to a ribosomal RNA probe to correct for any differ- 
ences in gel loading, confirmed that the distribution of MT-I 
mRNA paralleled that of c-myc with the an enrichment in the 
CBP fraction (Table 1): approximately 55% of both MT-I and 
c-myc mRNAs was recovered in the CBP fraction. The recov- 
ery of c-myc and MT-I in these polysomes occurs under condi- 
tions where there are comparable amounts of total mRNA in 
FP, CBP and MBP, thus indicating that the observed enrich- 
ment of MT-I and c-myc mRNAs in CBP is not due to a some 
non-specific effect. Reprobing these filters with a second spe- 
cific oligonucleotide showed that there was a significantly lower 
(P < 0.05) enrichment of MT-II mRNA in CBP, and a small 
but significant reduction in the proportion of the MT-II mRNA 
recovered in CBP (Table 1). 
3.3. In situ hybridization 
In situ hybridization of H4 cells was carried out using the 
same oligonucleotide as was used in the Northern blot analysis, 
but in this case labelled with biotin. As shown in Fig. 3 visual 
inspection showed a much greater staining in cells in which 
MT-I was induced by 6/.tg/ml zinc (Fig. 3b) compared to unin- 
duced cells (Fig. 3a), as expected from the results of Northern 
hybridisation showing a marked (five-fold) increase in MT 
mRNA under these conditions (Fig. 1). At higher magnification 
Table 1 
Quantification of the distribution of c-myc, glut-l, MT-I and MT-II mRNA in free polysomes (FP), cytoskeletal-bound polysomes (CBP) and 
membrane-bound polysomes (MBP) 
mRNA Transcript abundance (n = 3) Percentage of total transcript (n = 3) 
FP CBP MBP FP CBP MBP 
c-myc 100 202 + 19 139 + 15 15 + 4 56 + 2 28 + 1 
glut-1 100 169 + 59 390 + 90 14 + 4 27 + 1 58 + 5 
MT-I 100 170 + 9* 99 + 12 18 + 3 55 + 2 25 + 2 
MT-II 100 131 + 7* 108 + 17 23 + 4 49 + 1 28 + 5 
The transcript abundance values are expressed per unit 18s rRNA and were normalized taking the abundance of FP as 100 for each experiment. 
The 'percentage of total transcript' values were calculated by firstly determing the total counts present in each fraction for each transcript (knowing 
the volume of fraction loaded and the total volume of fraction) and then summing these values and obtaining the percentage of this sum which was 
attributable to each fraction. Errors are expressed as S.E.M. Enrichments in CBP were compared using a Student's t-test, *P < 0.05. 
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Fig. 3. In situ hybridisation showing the distribution of MT-I mRNA 
in rat hepatoma (H4) cells. Cells were hybridised with an biotin-labelled 
oligonucleotide probe specific for MT-I mRNA. Specific labelling was 
detected using steptavidin linked to alkaline phosphatase and 4-ni- 
troblue tetrazolium as substrate. (A) cells in which MT was induced 
with 6/.tg/ml Zn for 18 h. (B) uninduced cells grown in normal medium 
which was not supplemented with additional Zn. (C) picture at higher 
magnification f cells in which MT was induced with 6/.tg/ml Zn for 
18 h. (D) control cells which were not hybridized with the biotinylated 
MT-I probe. (E) control cells which were treated with RNAse A before 
hybridisation with the probe. Bar represents 10/lm. 
it was evident that in the induced cells (Fig. 3e) the staining was 
predominantly perinuclear. Cells which were either not incu- 
bated with the labelled oligonucleotide (Fig. 3d) or which were 
pre-treated with RNase before hybridisation (Fig. 3e) showed 
a very low level of non-specific staining. 
4. Discussion 
The present results how that the MT-I mRNA is enriched 
in polysomes which are released, along with significant 
amounts of actin and vimentin proteins, from the cell matrix 
by salt; therefore, they indicate that MT-I mRNA is translated 
in association with the cytoskeleton. In addition, the in situ 
hybridisation data suggest that the MT-I mRNA is not found 
equally distributed throughout the cytoplasm but is predomi- 
nantly in the cytoplasm around the nucleus and not in the 
peripheral cytoplasm. Further localisation is hindered by the 
limited volume of cytoplasm present in these cells. 
In HepG2 cells c-myc, cyclinA and two ribosomal protein 
mRNAs [22] have been found to be enriched in CBP and, on 
the basis of these results and the perinuclear localisation of 
c-myc mRNA [27], it has been suggested that one class of 
mRNAs found on CBPs is that corresponding to the mRNAs 
encoding proteins which are transported into the nucleus. The 
finding that MT-I mRNA is enriched in CBP could be related 
to the observations that during cell proliferation [17], early 
mammalian development [18], and possibly after metal oading 
[28] MT is found in the nucleus. It is possible therefore that the 
positioning of the MT-I mRNA around the nucleus and in CBP 
results in synthesis of the protein in the perinuclear cytoplasm 
so that under appropriate conditions it can be transported into 
the nucleus. Furthermore, the translation of the MT-I mRNA 
in association with the cytoskeleton might suggest the possible 
involvement of cytoskeletal filaments in this translocation 
process. Alternatively, the cytoskeleton-associated translation 
of MT-I mRNA may reflect a role of the newly made MT 
protein in protecting the cytoskeleton since it has been shown 
that cultured cells exposed to cadmium and nickel have altered 
cytoskeletal organisation [29]. 
The observation that the mRNAs for r -  and -isoforms of 
actin are differentially ocated within myoblasts [30] suggests 
that for intracellular p oteins which exist as isoforms, the differ- 
ential localisation of the isoform mRNAs may provide a means 
whereby cells can synthesise different isoforms in separate com- 
partments for subsequent targeting of the proteins to specific 
subcellular sites; in turn this may confer the isoforms with 
different functions. Analysis of MT-II mRNA distribution i  
H4 cells indicates that the enrichment of the MT-II transcript 
in CBP is less than that of the MT-I transcript, although some 
49% of the MT-II mRNA was recovered in CBP. These data 
suggest that the MT-II mRNA is associated with CBP but more 
weakly than MT-I mRNA and, in turn this implies that there 
is some compartmentation of MT-I and MT-II mRNAs. How- 
ever, the present observations have been made on only a single 
cell line and further studies are required to determine whether 
MT isoform mRNAs are translated in different subcellular 
locations in order to functionally differentiate between MT 
isoforms. 
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